Specialty Business Services
Compare Stocks
4 / 10Stock Comparison
ARMK vs ECL vs TRMK vs CHD
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Banks - Regional
Household & Personal Products
ARMK vs ECL vs TRMK vs CHD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Business Services | Chemicals - Specialty | Banks - Regional | Household & Personal Products |
| Market Cap | $11.84B | $72.46B | $2.64B | $22.24B |
| Revenue (TTM) | $18.79B | $16.08B | $1.12B | $6.21B |
| Net Income (TTM) | $317M | $2.08B | $224M | $733M |
| Gross Margin | 7.0% | 44.5% | 71.0% | 45.1% |
| Operating Margin | 4.2% | 17.7% | 25.5% | 17.3% |
| Forward P/E | 20.3x | 30.6x | 11.5x | 25.0x |
| Total Debt | $5.72B | $9.43B | $1.12B | $2.21B |
| Cash & Equiv. | $639M | $646M | $668M | $409M |
ARMK vs ECL vs TRMK vs CHD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Aramark (ARMK) | 100 | 241.1 | +141.1% |
| Ecolab Inc. (ECL) | 100 | 120.7 | +20.7% |
| Trustmark Corporati… (TRMK) | 100 | 188.7 | +88.7% |
| Church & Dwight Co.… (CHD) | 100 | 125.1 | +25.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ARMK vs ECL vs TRMK vs CHD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ARMK is the clearest fit if your priority is growth exposure.
- Rev growth 6.4%, EPS growth 23.2%, 3Y rev CAGR 10.6%
ECL is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 139.5% 10Y total return vs TRMK's 127.7%
- 8.8% ROA vs TRMK's 1.2%, ROIC 12.7% vs 7.1%
TRMK carries the broadest edge in this set and is the clearest fit for growth and value.
- 34.8% NII/revenue growth vs CHD's 1.6%
- Lower P/E (11.5x vs 25.0x)
- 20.0% margin vs ARMK's 1.7%
- 2.2% yield, 1-year raise streak, vs CHD's 1.3%
CHD is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 23 yrs, beta 0.14, yield 1.3%
- Lower volatility, beta 0.14, Low D/E 55.1%, current ratio 1.07x
- Beta 0.14, yield 1.3%, current ratio 1.07x
- Beta 0.14 vs TRMK's 0.94
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.8% NII/revenue growth vs CHD's 1.6% | |
| Value | Lower P/E (11.5x vs 25.0x) | |
| Quality / Margins | 20.0% margin vs ARMK's 1.7% | |
| Stability / Safety | Beta 0.14 vs TRMK's 0.94 | |
| Dividends | 2.2% yield, 1-year raise streak, vs CHD's 1.3% | |
| Momentum (1Y) | +32.5% vs ECL's +2.0% | |
| Efficiency (ROA) | 8.8% ROA vs TRMK's 1.2%, ROIC 12.7% vs 7.1% |
ARMK vs ECL vs TRMK vs CHD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ARMK vs ECL vs TRMK vs CHD — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TRMK leads in 4 of 6 categories
ARMK leads 0 • ECL leads 0 • CHD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TRMK leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARMK is the larger business by revenue, generating $18.8B annually — 16.8x TRMK's $1.1B. TRMK is the more profitable business, keeping 20.0% of every revenue dollar as net income compared to ARMK's 1.7%. On growth, ARMK holds the edge at +6.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $18.8B | $16.1B | $1.1B | $6.2B |
| EBITDAEarnings before interest/tax | $1.3B | $3.5B | $323M | $1.3B |
| Net IncomeAfter-tax profit | $317M | $2.1B | $224M | $733M |
| Free Cash FlowCash after capex | $257M | $1.9B | $230M | $1.1B |
| Gross MarginGross profit ÷ Revenue | +7.0% | +44.5% | +71.0% | +45.1% |
| Operating MarginEBIT ÷ Revenue | +4.2% | +17.7% | +25.5% | +17.3% |
| Net MarginNet income ÷ Revenue | +1.7% | +12.9% | +20.0% | +11.8% |
| FCF MarginFCF ÷ Revenue | +1.4% | +11.8% | +20.7% | +17.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.1% | +4.8% | — | +0.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.7% | +19.3% | +5.4% | +2.2% |
Valuation Metrics
TRMK leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, TRMK trades at a 67% valuation discount to ARMK's 36.9x P/E. On an enterprise value basis, TRMK's 9.5x EV/EBITDA is more attractive than ECL's 22.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $11.8B | $72.5B | $2.6B | $22.2B |
| Enterprise ValueMkt cap + debt − cash | $16.9B | $81.2B | $3.1B | $24.0B |
| Trailing P/EPrice ÷ TTM EPS | 36.93x | 35.24x | 12.13x | 31.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.26x | 30.64x | 11.50x | 25.01x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.50x | — |
| EV / EBITDAEnterprise value multiple | 13.35x | 22.66x | 9.49x | 18.14x |
| Price / SalesMarket cap ÷ Revenue | 0.64x | 4.51x | 2.36x | 3.59x |
| Price / BookPrice ÷ Book value/share | 3.81x | 7.46x | 1.28x | 5.73x |
| Price / FCFMarket cap ÷ FCF | 26.06x | 38.05x | 11.39x | 20.35x |
Profitability & Efficiency
TRMK leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ECL delivers a 22.0% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $10 for ARMK. TRMK carries lower financial leverage with a 0.53x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARMK's 1.81x. On the Piotroski fundamental quality scale (0–9), ARMK scores 7/9 vs ECL's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.8% | +22.0% | +10.8% | +17.4% |
| ROA (TTM)Return on assets | +2.4% | +8.8% | +1.2% | +8.2% |
| ROICReturn on invested capital | +7.3% | +12.7% | +7.1% | +13.9% |
| ROCEReturn on capital employed | +8.7% | +15.8% | +3.2% | +14.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.81x | 0.96x | 0.53x | 0.55x |
| Net DebtTotal debt minus cash | $5.1B | $8.8B | $448M | $1.8B |
| Cash & Equiv.Liquid assets | $639M | $646M | $668M | $409M |
| Total DebtShort + long-term debt | $5.7B | $9.4B | $1.1B | $2.2B |
| Interest CoverageEBIT ÷ Interest expense | 2.20x | 9.82x | 0.75x | 15.59x |
Total Returns (Dividends Reinvested)
TRMK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARMK five years ago would be worth $17,052 today (with dividends reinvested), compared to $11,370 for CHD. Over the past 12 months, TRMK leads with a +32.5% total return vs ECL's +2.0%. The 3-year compound annual growth rate (CAGR) favors TRMK at 29.8% vs CHD's 0.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.5% | -2.0% | +15.5% | +14.0% |
| 1-Year ReturnPast 12 months | +19.0% | +2.0% | +32.5% | +3.4% |
| 3-Year ReturnCumulative with dividends | +87.4% | +52.7% | +118.5% | +0.7% |
| 5-Year ReturnCumulative with dividends | +70.5% | +17.3% | +47.6% | +13.7% |
| 10-Year ReturnCumulative with dividends | +97.1% | +139.5% | +127.7% | +113.6% |
| CAGR (3Y)Annualised 3-year return | +23.3% | +15.2% | +29.8% | +0.2% |
Risk & Volatility
Evenly matched — TRMK and CHD each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHD is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than TRMK's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRMK currently trades 97.6% from its 52-week high vs ECL's 83.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.71x | 0.63x | 0.94x | 0.14x |
| 52-Week HighHighest price in past year | $46.88 | $309.27 | $45.99 | $106.04 |
| 52-Week LowLowest price in past year | $35.07 | $249.04 | $33.39 | $81.33 |
| % of 52W HighCurrent price vs 52-week peak | +96.1% | +83.0% | +97.6% | +88.5% |
| RSI (14)Momentum oscillator 0–100 | 62.0 | 46.0 | 56.0 | 49.1 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 1.4M | 392K | 1.8M |
Analyst Outlook
Evenly matched — TRMK and CHD each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ARMK as "Buy", ECL as "Buy", TRMK as "Hold", CHD as "Buy". Consensus price targets imply 27.5% upside for ECL (target: $327) vs 1.4% for TRMK (target: $46). For income investors, TRMK offers the higher dividend yield at 2.15% vs ARMK's 0.92%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $47.20 | $327.11 | $45.50 | $99.60 |
| # AnalystsCovering analysts | 24 | 37 | 9 | 34 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.0% | +2.2% | +1.3% |
| Dividend StreakConsecutive years of raises | 1 | 12 | 1 | 23 |
| Dividend / ShareAnnual DPS | $0.41 | $2.64 | $0.97 | $1.18 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | +1.1% | +3.0% | +4.0% |
TRMK leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
ARMK vs ECL vs TRMK vs CHD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ARMK or ECL or TRMK or CHD a better buy right now?
For growth investors, Trustmark Corporation (TRMK) is the stronger pick with 34.
8% revenue growth year-over-year, versus 1. 6% for Church & Dwight Co. , Inc. (CHD). Trustmark Corporation (TRMK) offers the better valuation at 12. 1x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate Aramark (ARMK) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ARMK or ECL or TRMK or CHD?
On trailing P/E, Trustmark Corporation (TRMK) is the cheapest at 12.
1x versus Aramark at 36. 9x. On forward P/E, Trustmark Corporation is actually cheaper at 11. 5x.
03Which is the better long-term investment — ARMK or ECL or TRMK or CHD?
Over the past 5 years, Aramark (ARMK) delivered a total return of +70.
5%, compared to +13. 7% for Church & Dwight Co. , Inc. (CHD). Over 10 years, the gap is even starker: ECL returned +139. 5% versus ARMK's +97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ARMK or ECL or TRMK or CHD?
By beta (market sensitivity over 5 years), Church & Dwight Co.
, Inc. (CHD) is the lower-risk stock at 0. 14β versus Trustmark Corporation's 0. 94β — meaning TRMK is approximately 579% more volatile than CHD relative to the S&P 500. On balance sheet safety, Trustmark Corporation (TRMK) carries a lower debt/equity ratio of 53% versus 181% for Aramark — giving it more financial flexibility in a downturn.
05Which is growing faster — ARMK or ECL or TRMK or CHD?
By revenue growth (latest reported year), Trustmark Corporation (TRMK) is pulling ahead at 34.
8% versus 1. 6% for Church & Dwight Co. , Inc. (CHD). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -1. 2% for Ecolab Inc.. Over a 3-year CAGR, ARMK leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ARMK or ECL or TRMK or CHD?
Trustmark Corporation (TRMK) is the more profitable company, earning 20.
0% net margin versus 1. 8% for Aramark — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRMK leads at 25. 5% versus 4. 3% for ARMK. At the gross margin level — before operating expenses — TRMK leads at 71. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ARMK or ECL or TRMK or CHD more undervalued right now?
On forward earnings alone, Trustmark Corporation (TRMK) trades at 11.
5x forward P/E versus 30. 6x for Ecolab Inc. — 19. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ECL: 27. 5% to $327. 11.
08Which pays a better dividend — ARMK or ECL or TRMK or CHD?
All stocks in this comparison pay dividends.
Trustmark Corporation (TRMK) offers the highest yield at 2. 2%, versus 0. 9% for Aramark (ARMK).
09Is ARMK or ECL or TRMK or CHD better for a retirement portfolio?
For long-horizon retirement investors, Church & Dwight Co.
, Inc. (CHD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 3% yield, +113. 6% 10Y return). Both have compounded well over 10 years (CHD: +113. 6%, TRMK: +127. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ARMK and ECL and TRMK and CHD?
These companies operate in different sectors (ARMK (Industrials) and ECL (Basic Materials) and TRMK (Financial Services) and CHD (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ARMK is a mid-cap quality compounder stock; ECL is a mid-cap quality compounder stock; TRMK is a small-cap high-growth stock; CHD is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.